0001125345-22-000049.txt : 20220517 0001125345-22-000049.hdr.sgml : 20220517 20220517172028 ACCESSION NUMBER: 0001125345-22-000049 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220516 FILED AS OF DATE: 20220517 DATE AS OF CHANGE: 20220517 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Koenig Scott CENTRAL INDEX KEY: 0001587514 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36112 FILM NUMBER: 22935910 MAIL ADDRESS: STREET 1: 9640 MEDICAL CENTER DRIVE CITY: ROCKVILLE STATE: MD ZIP: 20850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MACROGENICS INC CENTRAL INDEX KEY: 0001125345 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9704 MEDICAL CENTER DRIVE CITY: Rockville STATE: MD ZIP: 20850 BUSINESS PHONE: 301-251-5172 MAIL ADDRESS: STREET 1: 9704 MEDICAL CENTER DRIVE CITY: ROCKVILLE STATE: MD ZIP: 20850 4 1 wf-form4_165282239043395.xml FORM 4 X0306 4 2022-05-16 0 0001125345 MACROGENICS INC MGNX 0001587514 Koenig Scott 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 1 1 0 0 President and CEO Common Stock 2022-05-16 4 M 0 53265 1.51 A 1049636 D Employee stock option (right to buy) 1.51 2022-05-16 4 M 0 53265 1.51 D 2023-01-05 Common Stock 53265.0 0 D The transaction represents an exercise and hold of options. The shares are jointly owned with reporting person's spouse. 12.5% of the shares underlying the grant became exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter. /s/ Lynn Cilinski, Attorney-in-Fact 2022-05-17